Tobradex Eye Drops - Summary of Product Characteristics ...
Tobradex Eye Drops - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd
www.medicines.org.ukI don’t have live access to news feeds right now. Here’s a concise update based on recent reliable references and typical regulatory updates for Tobradex (tobramycin/dexamethasone) eye drops.
What Tobradex is: A combination antibiotic (tobramycin) and corticosteroid (dexamethasone) eye drop used to treat bacterial eye infections with inflammation. It carries familiar safety considerations related to steroids in the eye, such as potential for increased intraocular pressure with prolonged use, risk of secondary infections, and possible slower healing in some eyelid or corneal conditions. These safety points are consistently noted in official product information and regulatory summaries.[2][5]
Recent regulatory notes commonly emphasized: Use for the shortest duration necessary, monitor intraocular pressure if treatment is extended beyond a few days, and avoid use in viral or fungal infections unless advised. Patients should discontinue and contact a clinician if vision changes, severe eye pain, or signs of an allergic reaction occur. These cautions appear across multiple national labeling resources and consumer information PDFs.[3][6][7][2]
Practical considerations if you’re using Tobradex:
Availability and monitoring: Tobradex remains a widely prescribed brand in many markets, with multiple regulatory bodies hosting patient information and safety advisories. If you’re in Prague or the Czech Republic, or anywhere else, your local pharmacist or ophthalmologist can confirm current local guidance and any recent product updates or substitutions (some markets use Tobradex or generic equivalents).[6][5]
If you’d like, I can search for the latest country-specific regulatory notices or provide a quick checklist for safe use in your locale. Please share your country or region if you want precise, up-to-date references.
Citations:
Tobradex Eye Drops - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd
www.medicines.org.ukIn case patients are allowed to wear contact lenses, they must be instructed to remove contact lenses prior to application of TOBRADEX Eye Drops and wait at least 15 minutes before reinsertion. As the possibility of adverse effects on the corneal permeability and the danger of disruption of the corneal epithelium with prolonged or repeated usage of benzalkonium chloride
www.novartis.comeye to the brain) has been reported. If any of the following happen, stop using Tobradex Eye Drops and tell your doctor immediately or go to Accident and Emergency at your nearest hospital: • skin rash • swelling of the face, hands or feet
www.medsafe.govt.nzنظام معلومات الأدوية السعودي Saudi Drugs Information System
sdi.sfda.gov.saeye to the brain) has been reported. If any of the following happen, stop using Tobradex Eye Drops and tell your doctor immediately or go to Accident and Emergency at your nearest hospital: • skin rash • swelling of the face, hands or feet
www.medsafe.govt.nzFind patient medical information for Tobramycin/Dexamethasone (TobraDex) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
www.webmd.comTobradex Eye Drops - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd
www.medicines.org.uk